You are here: Home
Benefits of statin therapy may extend beyond lowering lipids

Benefits of statin therapy may extend beyond lowering lipids

People with high cholesterol are at risk of heart attack and stroke because atherosclerotic plaques within their arteries can rupture triggering the formation ...

Treating Cancer with Light

Treating Cancer with Light

New LED Device May Help Advance Photodynamic Therapy for Skin Cancer. Scientists at the University of California, Irvine (UC Irvine), believe so. They're explo...

Exploring Opportunities in Chemical Biology

Interview with: Torsten Hoffmann, Head Discovery Chemistry, F. Hoffmann – La Roche
Drug discovery scientists need to broaden their approaches to pharmaceutical...

Banner

Knowledge Bank

Edit

Amount of short articles:

Amount of articles links:

You can order sections with dragging on list bellow:

  • Knowledge Bank
  • Business & Industry
Save
Cancel
Reset

News

Hilleman signs MoU with Bangladesh firms to develop oral cholera

Hilleman Laboratories, a joint venture of Merck and Wellcome Trust, has signed a memorandum of understanding (MoU) with Bangladesh-based icddr,b and Incepta Vaccine to develop an oral cholera vaccine. The collaboration

Friday, 14 November 2014 Comments

Press Releases

GSK seeks European approval for eltrombopag to treat severe aplastic

British drug-maker GlaxoSmithKline (GSK) has submitted a marketing authorisation application to the European Medicines Agency (EMA) seeking an additional indication for eltrombopag

Friday, 14 November 2014 Comments

Research Insight

Hilleman signs MoU with Bangladesh firms to develop oral cholera

Hilleman Laboratories, a joint venture of Merck and Wellcome Trust, has signed a memorandum of understanding (MoU) with Bangladesh-based icddr,b and Incepta Vaccine to develop an oral cholera vaccine. The collaboration

Friday, 14 November 2014 Comments

Techno Trends

Insourcing IV Sterile

Determined to cement access to reliable and safe sources for crucial IV drug admixtures, a growing number of hospitals are bringing production of compounded sterile products (CSPs) in-house and turning

Wednesday, 25 June 2014 Comments

Industry Reports

Johnson & Johnson completes acquisition of AliosBioPharma for

US-based Johnson & Johnson (J&J) has completed the acquisition of a privately held clinical stage biopharmaceutical company, AliosBioPharma, for $1.75bn in

Friday, 14 November 2014 Comments

Articles

Oncology Treatment Adherence: Understanding the Patient

It would be easy to assume that an oral treatment that can halt the progression of a rare form of leukaemia would have high rates of adherence.

Tuesday, 14 August 2012 Comments

Business & Industry

Edit

Amount of short articles:

Amount of articles links:

You can order sections with dragging on list bellow:

  • Knowledge Bank
  • Business & Industry
Save
Cancel
Reset

Drug Research

Sanofi, Fraunhofer create new natural product center of

French pharmaceutical firm Sanofi and Germany-based Fraunhofer-Gesellschaft have formed a natural product center of excellence to speed up the discovery and development of new therapies to treat infectious

Friday, 17 January 2014 Comments

Production & Manufacturing

Galena Biopharma Acquires Mills

Galena Biopharma, a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, announced it has acquired Mills Pharmaceuticals, which has

Thursday, 16 January 2014 Comments

Packaging & Labelling

Canada unveils new labeling initiative to enhance drug

Canada has rolled out the plain language labeling initiative to improve the safe use of medicines by making drug labels and safety information easier to read and understand for all

Monday, 17 June 2013 Comments

Strategy

OncoMed Pharmaceuticals and Bayer HealthCare Expand Cancer Stem Cell Collaboration with Clinical Manufacturing

OncoMed Pharmaceuticals, Inc., a company developing novel therapeutics targeting cancer stem cells, today announced it has expanded its collaboration with Bayer HealthCare. Bayer’s U.S. affiliate will manufacture clinical supplies of

Saturday, 21 July 2012 Comments

Clinical Trials

Sanofi and Regeneron report positive Phase IIb trial results of dupilumab in asthma

Sanofi and Regeneron Pharmaceuticals have reported positive results from the interim analysis of a dose-ranging Phase IIb trial of dupilumab, a fully-human monoclonal antibody, in adult patients with uncontrolled moderate-to-severe

Friday, 14 November 2014 Comments

IT & Data Management

Pharma Security Group introduces new medication reminder

Pharma Security Group (PSG) has introduced a new medication reminder service, myPharmaCall, designed for users to set up daily phone call reminders for their

Thursday, 22 August 2013 Comments

Banner